Lorentz Brinch
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 28
- Acute Myeloid Leukemia Research 10
- Multiple Myeloma Research and Treatments 7
- Transplantation top 5%
- Genetics top 5%
- Oncology top 5%
- Neutropenia and Cancer Infections 6
- Immunology top 10%
-
- Transplantation: Methods and Outcomes 6
-
- Acute Lymphoblastic Leukemia research 6
-
- Childhood Cancer Survivors' Quality of Life 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 4
Lorentz Brinch
59 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 84
- Hematology 1.0k
- Transplantation 103
- Genetics 233
- Oncology 556
- Immunology 266
Countries citing papers authored by Lorentz Brinch
This map shows the geographic impact of Lorentz Brinch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorentz Brinch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorentz Brinch more than expected).
Fields of papers citing papers by Lorentz Brinch
This network shows the impact of papers produced by Lorentz Brinch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorentz Brinch. The network helps show where Lorentz Brinch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lorentz Brinch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 8 | |
| 4 | 2018 | 62 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 7 | |
| 7 | 2014 | 3 | |
| 8 | 2011 | 43 | |
| 9 | 2011 | 20 | |
| 10 | Allogen stamcelletransplantasjon med redusert forbehandling | 2007 | 2 |
| 11 | Klinisk bruk av hematopoetiske stamceller fra navlestrengsblod | 2004 | 1 |
| 12 | 2004 | 124 | |
| 13 | Paroksystisk nattlig hemoglobinuri – en sjelden sykdom med mange ansikter | 2002 | 2 |
| 14 | 2001 | 226 | |
| 15 | 1997 | 1 | |
| 16 | 1996 | 70 | |
| 17 | 1994 | 16 | |
| 18 | 1992 | 5 | |
| 19 | 1989 | 22 | |
| 20 | 1988 | 13 |
About Lorentz Brinch
Lorentz Brinch is a scholar working on Hematology, Transplantation, Oncology, Genetics and Immunology, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (7 papers), Transplantation: Methods and Outcomes (6 papers), Neutropenia and Cancer Infections (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). The work is most often cited by research in Hematology (1.0k citations), Transplantation (103 citations), Genetics (233 citations), Oncology (556 citations) and Immunology (266 citations). Lorentz Brinch has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Geir E. Tjønnfjord, Stig Lenhoff, Per Ljungman, Jan Westin, Johan Lanng Nielsen, Ingemar Turesson, Kristina Carlson, Peter Gimsing, Martin Hjorth and Finn Wislöff. Their work appears in journals such as Bone Marrow Transplantation, British Journal of Haematology, Blood, Journal of Internal Medicine and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.